nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—polycystic ovary syndrome	0.327	0.383	CbGaD
Drostanolone—AR—polycystic ovary syndrome	0.287	0.336	CbGaD
Drostanolone—CYP19A1—polycystic ovary syndrome	0.24	0.281	CbGaD
Drostanolone—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0315	0.341	CbGeAlD
Drostanolone—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0182	0.196	CbGeAlD
Drostanolone—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0142	0.154	CbGeAlD
Drostanolone—CYP19A1—Ovarian Infertility Genes—GDF9—polycystic ovary syndrome	0.00354	0.0783	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.00325	0.0719	CbGpPWpGaD
Drostanolone—Ursodeoxycholic acid—AKR1C2—polycystic ovary syndrome	0.00218	0.243	CrCbGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AR—polycystic ovary syndrome	0.00184	0.0406	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—SHBG—polycystic ovary syndrome	0.00175	0.0388	CbGpPWpGaD
Drostanolone—SHBG—endometrium—polycystic ovary syndrome	0.00173	0.0187	CbGeAlD
Drostanolone—Trilostane—HSD3B1—polycystic ovary syndrome	0.00173	0.193	CrCbGaD
Drostanolone—SHBG—uterus—polycystic ovary syndrome	0.0016	0.0173	CbGeAlD
Drostanolone—AR—Coregulation of Androgen receptor activity—TMF1—polycystic ovary syndrome	0.00158	0.035	CbGpPWpGaD
Drostanolone—SHBG—pituitary gland—polycystic ovary syndrome	0.00157	0.017	CbGeAlD
Drostanolone—SHBG—adipose tissue—polycystic ovary syndrome	0.00156	0.0169	CbGeAlD
Drostanolone—CYP19A1—endometrium—polycystic ovary syndrome	0.00141	0.0152	CbGeAlD
Drostanolone—SHBG—adrenal gland—polycystic ovary syndrome	0.0014	0.0152	CbGeAlD
Drostanolone—AR—adrenal cortex—polycystic ovary syndrome	0.00139	0.0151	CbGeAlD
Drostanolone—CYP19A1—Ovarian Infertility Genes—LHCGR—polycystic ovary syndrome	0.00136	0.03	CbGpPWpGaD
Drostanolone—SHBG—female gonad—polycystic ovary syndrome	0.00131	0.0141	CbGeAlD
Drostanolone—SHBG—vagina—polycystic ovary syndrome	0.0013	0.014	CbGeAlD
Drostanolone—CYP19A1—uterus—polycystic ovary syndrome	0.00129	0.014	CbGeAlD
Drostanolone—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00127	0.0137	CbGeAlD
Drostanolone—AR—endometrium—polycystic ovary syndrome	0.00124	0.0135	CbGeAlD
Drostanolone—SHBG—endocrine gland—polycystic ovary syndrome	0.00122	0.0131	CbGeAlD
Drostanolone—Trilostane—HSD3B2—polycystic ovary syndrome	0.00117	0.13	CrCbGaD
Drostanolone—AR—uterus—polycystic ovary syndrome	0.00115	0.0124	CbGeAlD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A1—polycystic ovary syndrome	0.00114	0.0252	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—FSHR—polycystic ovary syndrome	0.00114	0.0252	CbGpPWpGaD
Drostanolone—CYP19A1—adrenal gland—polycystic ovary syndrome	0.00114	0.0123	CbGeAlD
Drostanolone—AR—pituitary gland—polycystic ovary syndrome	0.00113	0.0122	CbGeAlD
Drostanolone—AR—adipose tissue—polycystic ovary syndrome	0.00112	0.0121	CbGeAlD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—polycystic ovary syndrome	0.00109	0.024	CbGpPWpGaD
Drostanolone—CYP19A1—female gonad—polycystic ovary syndrome	0.00106	0.0115	CbGeAlD
Drostanolone—AR—adrenal gland—polycystic ovary syndrome	0.00101	0.0109	CbGeAlD
Drostanolone—AR—Nongenotropic Androgen signaling—GNRH1—polycystic ovary syndrome	0.00101	0.0223	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—FSHR—polycystic ovary syndrome	0.000992	0.022	CbGpPWpGaD
Drostanolone—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000985	0.0107	CbGeAlD
Drostanolone—AR—female gonad—polycystic ovary syndrome	0.000938	0.0101	CbGeAlD
Drostanolone—AR—vagina—polycystic ovary syndrome	0.000932	0.0101	CbGeAlD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B1—polycystic ovary syndrome	0.000923	0.0204	CbGpPWpGaD
Drostanolone—AR—endocrine gland—polycystic ovary syndrome	0.000872	0.00943	CbGeAlD
Drostanolone—CYP19A1—Endogenous sterols—CYP11A1—polycystic ovary syndrome	0.000867	0.0192	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—LHB—polycystic ovary syndrome	0.000842	0.0186	CbGpPWpGaD
Drostanolone—Finasteride—SRD5A1—polycystic ovary syndrome	0.000838	0.0935	CrCbGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—HSD3B2—polycystic ovary syndrome	0.000823	0.0182	CbGpPWpGaD
Drostanolone—CYP19A1—Endogenous sterols—CYP17A1—polycystic ovary syndrome	0.000806	0.0178	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—polycystic ovary syndrome	0.00065	0.0144	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PGR—polycystic ovary syndrome	0.000621	0.0137	CbGpPWpGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—PGR—polycystic ovary syndrome	0.000613	0.0136	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP17A1—polycystic ovary syndrome	0.000604	0.0134	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—CAMK2D—polycystic ovary syndrome	0.000537	0.0119	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PGR—polycystic ovary syndrome	0.000491	0.0109	CbGpPWpGaD
Drostanolone—Stanozolol—AR—polycystic ovary syndrome	0.00047	0.0524	CrCbGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—polycystic ovary syndrome	0.000466	0.0103	CbGpPWpGaD
Drostanolone—Oxandrolone—AR—polycystic ovary syndrome	0.000423	0.0472	CrCbGaD
Drostanolone—CYP19A1—Ovarian Infertility Genes—NCOR1—polycystic ovary syndrome	0.000417	0.00922	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000403	0.00892	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000397	0.0088	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—NR3C1—polycystic ovary syndrome	0.00039	0.00864	CbGpPWpGaD
Drostanolone—CYP19A1—Endogenous sterols—POMC—polycystic ovary syndrome	0.000383	0.00849	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000377	0.00835	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000374	0.00829	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ZNF430—polycystic ovary syndrome	0.000371	0.0082	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ZNF205—polycystic ovary syndrome	0.000371	0.0082	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00037	0.00818	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—NCOR1—polycystic ovary syndrome	0.000356	0.00788	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000326	0.00723	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—NR3C1—polycystic ovary syndrome	0.000309	0.00683	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000304	0.00672	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—PPARG—polycystic ovary syndrome	0.000302	0.00669	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—NR3C1—polycystic ovary syndrome	0.000299	0.00662	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—polycystic ovary syndrome	0.000296	0.00655	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000295	0.00654	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—polycystic ovary syndrome	0.000287	0.00636	CbGpPWpGaD
Drostanolone—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000282	0.0315	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.000276	0.00611	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—INS—polycystic ovary syndrome	0.000264	0.00584	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000246	0.00545	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—PPARG—polycystic ovary syndrome	0.000239	0.00529	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000239	0.00529	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000236	0.00522	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOR1—polycystic ovary syndrome	0.00023	0.0051	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—NCOR1—polycystic ovary syndrome	0.000214	0.00473	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—polycystic ovary syndrome	0.000213	0.00472	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.00021	0.00465	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—TEAD2—polycystic ovary syndrome	0.000203	0.0045	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000196	0.00433	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000194	0.00429	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000193	0.00427	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.000186	0.00411	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000183	0.00404	CbGpPWpGaD
Drostanolone—Medrysone—NR3C1—polycystic ovary syndrome	0.000179	0.02	CrCbGaD
Drostanolone—AR—Gene Expression—ZNF205—polycystic ovary syndrome	0.000178	0.00395	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ZNF430—polycystic ovary syndrome	0.000178	0.00395	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000178	0.00394	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.000175	0.00388	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000173	0.00384	CbGpPWpGaD
Drostanolone—Testosterone Propionate—AR—polycystic ovary syndrome	0.000172	0.0191	CrCbGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000171	0.00379	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000171	0.00378	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000168	0.00373	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—CYP19A1—polycystic ovary syndrome	0.000165	0.00364	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000162	0.00358	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000161	0.00357	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000159	0.00352	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ATF1—polycystic ovary syndrome	0.000157	0.00348	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ADARB1—polycystic ovary syndrome	0.000152	0.00336	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—polycystic ovary syndrome	0.000149	0.00329	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000147	0.00325	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000147	0.00325	CbGpPWpGaD
Drostanolone—Methyltestosterone—SHBG—polycystic ovary syndrome	0.000146	0.0163	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TAB1—polycystic ovary syndrome	0.000145	0.00321	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000144	0.0032	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AR—polycystic ovary syndrome	0.000138	0.00305	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000136	0.00302	CbGpPWpGaD
Drostanolone—Progesterone—CYP17A1—polycystic ovary syndrome	0.00013	0.0145	CrCbGaD
Drostanolone—Methyltestosterone—AR—polycystic ovary syndrome	0.000128	0.0143	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000126	0.00279	CbGpPWpGaD
Drostanolone—AR—Gene Expression—LSM5—polycystic ovary syndrome	0.000124	0.00274	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000123	0.00272	CbGpPWpGaD
Drostanolone—Testosterone—CYP11A1—polycystic ovary syndrome	0.000121	0.0134	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BAX—polycystic ovary syndrome	0.000117	0.0026	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000117	0.00258	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SAP30L—polycystic ovary syndrome	0.000115	0.00255	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000113	0.0025	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000111	0.00246	CbGpPWpGaD
Drostanolone—Methyltestosterone—CYP19A1—polycystic ovary syndrome	0.000107	0.012	CrCbGaD
Drostanolone—Estradiol—SHBG—polycystic ovary syndrome	0.000106	0.0118	CrCbGaD
Drostanolone—CYP19A1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000103	0.00228	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	0.000103	0.00227	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000101	0.00225	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TEAD2—polycystic ovary syndrome	9.78e-05	0.00216	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—YAP1—polycystic ovary syndrome	9.7e-05	0.00215	CbGpPWpGaD
Drostanolone—Progesterone—PGR—polycystic ovary syndrome	9.61e-05	0.0107	CrCbGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	9.46e-05	0.0021	CbGpPWpGaD
Drostanolone—Estradiol—AR—polycystic ovary syndrome	9.28e-05	0.0104	CrCbGaD
Drostanolone—CYP19A1—Metabolism—NMNAT3—polycystic ovary syndrome	9.05e-05	0.002	CbGpPWpGaD
Drostanolone—Progesterone—SHBG—polycystic ovary syndrome	8.98e-05	0.01	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—IRS1—polycystic ovary syndrome	8.84e-05	0.00196	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	8.63e-05	0.00191	CbGpPWpGaD
Drostanolone—Testosterone—SHBG—polycystic ovary syndrome	8.49e-05	0.00948	CrCbGaD
Drostanolone—AR—Generic Transcription Pathway—PGR—polycystic ovary syndrome	8.47e-05	0.00188	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	8.44e-05	0.00187	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	8.3e-05	0.00184	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LPCAT2—polycystic ovary syndrome	8.27e-05	0.00183	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SUOX—polycystic ovary syndrome	8.27e-05	0.00183	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	8.17e-05	0.00181	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	7.88e-05	0.00175	CbGpPWpGaD
Drostanolone—Progesterone—AR—polycystic ovary syndrome	7.88e-05	0.00879	CrCbGaD
Drostanolone—CYP19A1—Metabolism—ISYNA1—polycystic ovary syndrome	7.69e-05	0.0017	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—POMC—polycystic ovary syndrome	7.67e-05	0.0017	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	7.52e-05	0.00166	CbGpPWpGaD
Drostanolone—Testosterone—AR—polycystic ovary syndrome	7.45e-05	0.00831	CrCbGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—polycystic ovary syndrome	7.15e-05	0.00158	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.02e-05	0.00155	CbGpPWpGaD
Drostanolone—AR—Gene Expression—RPL37A—polycystic ovary syndrome	6.97e-05	0.00154	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	6.88e-05	0.00152	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	6.66e-05	0.00147	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKR1C2—polycystic ovary syndrome	6.54e-05	0.00145	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TEAD2—polycystic ovary syndrome	6.54e-05	0.00145	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.29e-05	0.00139	CbGpPWpGaD
Drostanolone—Testosterone—CYP19A1—polycystic ovary syndrome	6.23e-05	0.00695	CrCbGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	6.21e-05	0.00138	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.19e-05	0.00137	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	6.05e-05	0.00134	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	5.76e-05	0.00128	CbGpPWpGaD
Drostanolone—Estradiol—CYP1A1—polycystic ovary syndrome	5.72e-05	0.00638	CrCbGaD
Drostanolone—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	5.48e-05	0.00121	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	5.35e-05	0.00118	CbGpPWpGaD
Drostanolone—Progesterone—NR3C1—polycystic ovary syndrome	5.34e-05	0.00596	CrCbGaD
Drostanolone—AR—Generic Transcription Pathway—NR3C1—polycystic ovary syndrome	5.33e-05	0.00118	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	5.2e-05	0.00115	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	5.15e-05	0.00114	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	4.96e-05	0.0011	CbGpPWpGaD
Drostanolone—Progesterone—CYP1A1—polycystic ovary syndrome	4.85e-05	0.00541	CrCbGaD
Drostanolone—AR—Gene Expression—YAP1—polycystic ovary syndrome	4.67e-05	0.00103	CbGpPWpGaD
Drostanolone—Testosterone—CYP1A1—polycystic ovary syndrome	4.59e-05	0.00512	CrCbGaD
Drostanolone—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	4.42e-05	0.000978	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	4.21e-05	0.000933	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	4.19e-05	0.000927	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.17e-05	0.000922	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.13e-05	0.000914	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TNRC6B—polycystic ovary syndrome	4.12e-05	0.000912	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PGR—polycystic ovary syndrome	4.08e-05	0.000903	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.95e-05	0.000874	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	3.84e-05	0.000851	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	3.76e-05	0.000832	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.72e-05	0.000823	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	3.64e-05	0.000805	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	3.35e-05	0.000741	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	3.24e-05	0.000718	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	3.13e-05	0.000692	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	3e-05	0.000665	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.99e-05	0.000661	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.97e-05	0.000657	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.94e-05	0.000652	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.8e-05	0.00062	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NCOR1—polycystic ovary syndrome	2.77e-05	0.000614	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.76e-05	0.00061	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NR3C1—polycystic ovary syndrome	2.57e-05	0.000568	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TH—polycystic ovary syndrome	2.39e-05	0.000528	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	2.32e-05	0.000514	CbGpPWpGaD
Drostanolone—AR—Gene Expression—PPARG—polycystic ovary syndrome	1.99e-05	0.00044	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	1.95e-05	0.000431	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.86e-05	0.000411	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.79e-05	0.000396	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.76e-05	0.000389	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.64e-05	0.000363	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.33e-05	0.000294	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.31e-05	0.00029	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.3e-05	0.000289	CbGpPWpGaD
